Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells
1998
Effects of Gemcitabine on Mouse Jejunum Radiosensitization
Sample size: 6
publication
Author Information
Author(s): V Gr6goire, M Beauduin, J-F Rosier, B De Coster, M Bruiaux, M Octave-Prignot, P Scalliet
Hypothesis
The study investigates the relationship between gemcitabine treatment and radiosensitization in mouse jejunum.
Conclusion
Gemcitabine enhances the tolerance of mouse jejunum to radiation when administered before irradiation.
Supporting Evidence
- Gemcitabine was administered at a dose of 150 mg/kg.
- Jejunal crypt regeneration was assessed after irradiation.
- DNA synthesis inhibition was measured using BrdUrd labeling.
Takeaway
Giving mice a medicine called gemcitabine before radiation helps their intestines handle the radiation better.
Methodology
Mice were treated with gemcitabine and then irradiated; jejunum samples were analyzed for crypt regeneration and DNA synthesis.
Participant Demographics
Mice were used in the study.
Want to read the original?
Access the complete publication on the publisher's website